- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/20 - Pills, lozenges or tablets
Patent holdings for IPC class A61K 9/20
Total number of patents in this class: 13890
10-year publication summary
1140
|
1256
|
1175
|
1292
|
1281
|
1259
|
1102
|
1049
|
942
|
425
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 10963 |
145 |
Sanovel Ilac Sanayi ve Ticaret A.S. | 274 |
130 |
Fertin Pharma A/S | 252 |
106 |
Antecip Bioventures II LLC | 325 |
95 |
Boehringer Ingelheim International GmbH | 4702 |
92 |
Takeda Pharmaceutical Company Limited | 2703 |
92 |
Axsome Therapeutics, Inc. | 242 |
84 |
ratiopharm GmbH | 309 |
83 |
Synthon BV | 309 |
76 |
Daiichi Sankyo Company, Limited | 1849 |
75 |
Merck Patent GmbH | 5831 |
73 |
Purdue Pharma L.P. | 499 |
69 |
Hanmi Pharm. Co., Ltd. | 568 |
67 |
Vertex Pharmaceuticals Incorporated | 1589 |
60 |
AstraZeneca AB | 2928 |
59 |
Gilead Sciences, Inc. | 2018 |
57 |
Novo Nordisk A/S | 2289 |
56 |
Hoffmann-La Roche Inc. | 3357 |
55 |
Lupin Limited | 433 |
55 |
DSM IP Assets B.V. | 5672 |
54 |
Other owners | 12307 |